Featuring interviews with industry leaders, pioneering researchers, and influential entrepreneurs, Favorable Environments offers listeners a unique perspective into the minds shaping the future of medical technology and healthcare.
Favorable Environments is a podcast inspired by Nobel Prize-winning physicist and South Dakota inventor Ernest O. Lawrence. The conversations featured explore the essential resources that make innovation in medical technology possible. From stories of raising funds for commercialization to insights into creating thriving organizational culture, the show uncovers the elements that lay the groundwork for the future of healthcare and life sciences. This podcast is sponsored by the University of South Dakota Discovery District.
Ken Londoner has established himself as an authority in capital markets and capital architecture, as well as a prominent executive in the life sciences sector. He is the Chief Executive Officer of BioSig Technologies, Inc. [NASDAQ: BSGM].
Dr. Neel Patel is the co founder and CEO of Zio Health, a medtech company based in London, UK. After a career of being a physician, he stated ZiO Health and worked towards a shared goal with his team: bringing hospital-grade lab testing to the point-of-use, enhancing accessibility to molecular testing and optimizing health and sickness prevention. More specifically, they have developed a point-of-care therapeutic drug monitoring device which measures medication concentration levels to improve drug treatment outcomes.
Dr. Patel is also a Partner at HealthTech Investors, an angel syndicate that invests in founders working on the best solutions in improving healthcare.
Max G. Ostermeier (MBA) is the co-founder and General Manager of Implandata Ophthalmic Products GmbH. He brings extensive experience in the commercial development of advanced technologies, building operational capabilities for rapidly growing companies, and creating businesses that attract global acquirers.
As a serial entrepreneur, Max founded and managed Odicrain GmbH, a German medical device start-up that developed a pioneering portable device for the rapid detection of intracranial bleedings, which was acquired by a US-based company in 2007. He also co-founded and served as CEO of Cranium Telemetrics GmbH, a medical technology company specializing in innovative neurosurgical products, which was acquired by a leading US medical device company four years after its founding. Additionally, Max played a key role in establishing a biotech entity for a globally leading fine chemistry company, where he served as General Manager and Vice-President until its acquisition by Sigma Aldrich.
Have a guest suggestion or something you'd like to share? Please fill out the contact form and we will get back to you.